Evaluation of the Impact of Lung Ultrasound on Mortality and Rehospitalization in Patients Admitted to the Emergency Department With Dyspnea
HOSPITALUS
2 other identifiers
observational
385
1 country
1
Brief Summary
Dyspnea is a frequent reason for referral to emergency departments, leading to a 30-day mortality rate of up to 10% and a 3-month rehospitalization rate of over 30%. Multiple etiologies, as well as poor performance of clinical examination and chest radiography, lead to a diagnostic error rate of nearly 30% at the end of emergency department care. These diagnostic errors lead to rehospitalization and an excess mortality rate of more than 50% compared to patients with a correct initial diagnosis, which is explained in particular by the use of inappropriate therapies. Lung ultrasound is a rapid, non-irradiating, non-invasive, inexpensive, reproducible imaging test that can be used at the bedside. It has a better diagnostic performance than chest radiography, commonly performed in emergency departments.The immediate benefit of lung ultrasound for the most common diagnoses in emergency medicine has already been demonstrated. From an organizational point of view, a few studies have shown a benefit of lung ultrasound in reducing the time spent in emergency departments and the number of additional examinations necessary for the final diagnosis. However, there is no data in the literature on the longer term impact of its use in the emergency department. The primary objective is to evaluate the impact of performing lung ultrasound in terms of 3-month mortality and rehospitalization as part of the diagnostic process for patients admitted to the emergency department with dyspnea.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jun 2023
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 15, 2023
CompletedFirst Posted
Study publicly available on registry
March 28, 2023
CompletedStudy Start
First participant enrolled
June 16, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 28, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
November 28, 2025
CompletedJanuary 8, 2026
January 1, 2026
2.5 years
March 15, 2023
January 6, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
The primary objective is to evaluate the impact of performing lung ultrasound in terms of 3-month mortality as part of the diagnostic process for patients admitted to the emergency department with dyspnea.
The primary endpoint is the rate of mortality at 3 months.
at 3 months
The primary objective is to evaluate the impact of performing lung ultrasound in terms of 3-month rehospitalization as part of the diagnostic process for patients admitted to the emergency department with dyspnea.
the primary endpoint is the rate of rehospitalization at 3 months
at 3 months
Study Arms (2)
With Lung Ultrasonography
Patient who meet inclusions criteria, and which lung ultrasonography were performed during their medical care in Emergency Department
Without Lung Ultrasonography
Patient who meet inclusions criteria, and which lung ultrasonography were not performed during their medical care in Emergency Department.
Interventions
patients will be called at 3 months to know if they are alive and to know if they have been rehospitalized
Eligibility Criteria
This study will focus on adult patients consulting for dyspnea in the emergency department of the Edouard-Herriot Hospital (HCL).
You may qualify if:
- Age ≥ 18 years
- Admission to the emergency department with dyspnea defined by:
- The functional sign of dyspnea experienced by the patient; Or a clinical sign of respiratory distress.
- \- Non-opposition of the patient or patient's family if the patient isn't able
You may not qualify if:
- Trauma-induced dyspnea;
- Patient being on palliative care;
- Patient with criteria for initial resuscitation with admission to a critical care unit;
- Pregnant women, women in labour or nursing mothers;
- Persons deprived of liberty by judicial or administrative decision;
- Persons under psychiatric care;
- Persons admitted to a health or social institution for purposes other than research;
- Persons of full age subject to a legal protection measure (guardianship, curatorship);
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Hôpital Edouard-Herriot - Emergency Department
Lyon, 69003, France
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
JULIA MORERE, MD
Hospices Civils de Lyon
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 15, 2023
First Posted
March 28, 2023
Study Start
June 16, 2023
Primary Completion
November 28, 2025
Study Completion
November 28, 2025
Last Updated
January 8, 2026
Record last verified: 2026-01